Disseminated superficial actinic porokeratosis

Disseminated superficial actinic porokeratosis (DSAP) is the most common form of porokeratosis characterized by the presence of several small annular plaques with a distinctive keratotic rim found most commonly on sun-exposed areas of the skin, particularly the extremities.

患者の徴候・症状を入力

症例報告を絞り込む

合計: 27 （症例報告）

（表示件数）

対応する徴候・症状遺伝子変異キーワード（MeSH）

順位（類似度）	PMID (PMCID)
1 (17.5%)	21507038	Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream. Arun B, Pearson J, Chalmers R. Clin Exp Dermatol. 2011;36(5):509-11. [ 抄録を表示 ] [ 抄録を非表示 ]
		紅斑瘢痕


		アミノキノリンインターフェロン誘導剤ヒト汗孔角化症男皮膚適用薬物投与計画
2 (4.0%)	29630163	A report and follow up of a patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy. Howard M, Hall A. Dermatol Online J. 2018;24(2):. [ 抄録を表示 ] [ 抄録を非表示 ]
		基底細胞癌
		SERPINB3

		ヒトリンパ腫中枢神経系腫瘍汗孔角化症男経過観察酒さ
2 (4.0%)	28976625	Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: An unusual presentation leading to a novel therapeutic approach. Al-Haseni A, Chitgopeker P, Ho JD, Goldberg LJ, Sahni D. Dermatol Ther. 2018;31(1):. [ 抄録を表示 ] [ 抄録を非表示 ]
		黒色腫


		ヒト前癌状態包帯女抗悪性腫瘍性代謝拮抗薬汗孔角化症無色素性メラノーマ皮膚癌皮膚適用組織診腫瘍形質転換
2 (4.0%)	28922948	Clinical and Dermoscopic Features of Pigmented Disseminated Superficial Actinic Porokeratosis: Case Report and Literature Review. Sotoodian B, Mahmood MN, Salopek TG. J Cutan Med Surg. 2018;22(2):229-231. [ 抄録を表示 ] [ 抄録を非表示 ]
		Erythematous papule


		ダーモスコピーヒト太陽光汗孔角化症男皮膚組織診背中
2 (4.0%)	28398427	Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05. Anderson I, Routt ET, Jim On SC. Cutis. 2017;99(3):E36-E39. [ 抄録を表示 ] [ 抄録を非表示 ]
		Actinic keratosis


		ジテルペンヒト女成人汗孔角化症皮膚科用薬物皮膚適用
2 (4.0%)	27468973	Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel? Tchernev G, Chokoeva AA, Ivanova B, Mangarov H, Vidolova NG. Wien Med Wochenschr. 2017;167(3-4):85-88. [ 抄録を表示 ] [ 抄録を非表示 ]
		基底細胞癌


		80歳以上ヒト併用薬物療法女局所投与汗孔角化症脚部皮膚疾患薬物投与計画
2 (4.0%)	27086492	Linear porokeratosis with multiple squamous cell carcinomas successfully treated by electrochemotherapy. Sommerlad M, Lock A, Moir G, McGregor J, Bull R, Cerio R, Harwood C. Br J Dermatol. 2016;175(6):1342-1345. [ 抄録を表示 ] [ 抄録を非表示 ]
		基底細胞癌


		ヒトボーエン病中年抗悪性腫瘍性抗生物質汗孔角化症男皮膚癌腫瘍形質転換電気化学療法
2 (4.0%)	25800103	Eruptive disseminated porokeratosis associated with corticosteroid-induced immunosuppression. Bednarek R, Ezra N, Toubin Y, Linos K, Mousdicas N. Clin Exp Dermatol. 2015;40(7):753-6. [ 抄録を表示 ] [ 抄録を非表示 ]
		喘息


		ヒト免疫抑制薬副腎皮質ステロイド女成人汗孔角化症
2 (4.0%)	22148029 (3229955)	Squamous Cell Carcinoma Developing within Lesions of Disseminated Superficial Actinic Porokeratosis. Lee HR, Han TY, Son SJ, Lee JH. Ann Dermatol. 2011;23(4):536-8. [ 抄録を表示 ] [ 抄録を非表示 ]
		基底細胞癌



2 (4.0%)	21933257	Exclusive facial porokeratosis: histopathologically showing follicular cornoid lamellae. Lee Y, Choi EH. J Dermatol. 2011;38(11):1072-5. [ 抄録を表示 ] [ 抄録を非表示 ]
		斑


		ヒト女局所投与成人汗孔角化症顔面

徴候・症状リスト（Orphanetデータベースから取得）

合計: 4

HPO ID	徴候・症状	頻度
HP:0200044	汗孔角化症	Very frequent (99-80%)
HP:0000992	皮膚光線過敏症	Frequent (79-30%)
HP:0000989	掻痒	Occasional (29-5%)
HP:0002860	基底細胞癌	Occasional (29-5%)

徴候・症状リスト（症例報告から取得）

合計: 5

HPO ID	徴候・症状	症例報告数
HP:0002860	基底細胞癌	2
HP:0200034	丘疹	2
HP:0002664	新生物	1
HP:0020073	Hypopigmented macule	1
HP:0200039	膿疱	1

疾患原因遺伝子リスト（Orphanetデータベースから取得）